If you need more lookups,
subscriptions start at $34 USD/month.
Andrei Ogrel Location
Russell, ON, CA
Andrei Ogrel Work
2021 -now Senior Manager, CMC and Analytical Sciences @
2012 -now CMC advisor @ AO Biotech
2016 -2017 Lead, CMC and Analytical Sciences @
2012 -2016 Managing Director, Founder @ Oligomer Chemical Technologies Inc.
2014 -2015 CMC and Analytical Advisor @ International AIDS Vaccine Initiative (IAVI)
2004 -2012 Director of Vaccine Development @
2002 -2004 Senior Scientist @ PharmaGap Inc
2000 -2002 Research Associate @
Andrei Ogrel Education
Ph.D. (Chemistry)
Lomonosov Moscow Institute of Fine Chemical Technology
M.Sc. (Chemical Engineering, summa cum laude)
Andrei Ogrel Skills
Analytical Methods Development
Regulatory Submissions
Chemistry, Manufacturing, and Controls (CMC)
Contract Manufacturing
CRO Management
Biologics
Small Molecules
Quality Control
Peptide synthesis
Vaccine development
Formulation development
Target-based drug design
Analytical Chemistry
Research Project Management
GMP manufacturing
Process Development
Drug Discovery
Regulatory Requirements
Technology Transfer
CMC development
Good Laboratory Practice Glp
Target Based Drug Design
Chemistry
GMP
Biotechnology
Life Sciences
Stability Studies
Research and Development R&d
Vaccines
Formulation
Project Management
Process Simulation
Protein Chemistry
Good Laboratory Practice
Research and Development
Andrei Ogrel Summary
Andrei Ogrel, based in Russell, ON, CA, is currently a Senior Manager, CMC and Analytical Sciences at Mannin Research. Andrei Ogrel brings experience from previous roles at AO Biotech, Formation Biologics Inc., Oligomer Chemical Technologies Inc. and International AIDS Vaccine Initiative (IAVI). Andrei Ogrel holds a Ph.D. in Chemistry. With a robust skill set that includes Analytical Methods Development, Regulatory Submissions, Chemistry, Manufacturing, and Controls (CMC), Contract Manufacturing, CRO Management and more. Andrei Ogrel has 1 emails on RocketReach.
Looking for a different Andrei Ogrel?
Find contact details for 700 million professionals.